Pub Date : 2026-02-01Epub Date: 2026-02-25DOI: 10.1177/03000605261417865
Jia Di, Guo Xuan, Xu Shanshan, Yang Jianzhong
Ventilator-associated pneumonia substantially increases mortality and imposes a heavy burden on healthcare resources. Patients undergoing endotracheal intubation and mechanical ventilation in emergency departments face a particularly high risk of ventilator-associated pneumonia. Compared with healthcare providers in intensive care units, those in emergency departments often lack sufficient awareness of timely and systematic ventilator-associated pneumonia prevention strategies, and existing intensive care unit-based care bundles are rarely tailored to emergency department-specific constraints. This gap leads to suboptimal implementation of ventilator-associated pneumonia preventive measures and increases the risk of ventilator-associated pneumonia. In this narrative review, we synthesize the current evidence on ventilator-associated pneumonia prevention and assess the feasibility of care bundles in resource-constrained emergency department settings. We propose the use of position, hand hygiene, airway, sedation, and equipment-a structured, multicomponent ventilator-associated pneumonia prevention strategy-in emergency departments with limited resources, supported by enabling strategies such as electronic checklists, multidisciplinary collaboration, and training to ensure adherence. Moving forward, efforts should focus on establishing consensus on emergency department-specific ventilator-associated pneumonia prevention protocols and optimizing nursing resource allocation to support implementation.
{"title":"A potential bundle for preventing ventilator-associated pneumonia in the emergency department: A narrative review.","authors":"Jia Di, Guo Xuan, Xu Shanshan, Yang Jianzhong","doi":"10.1177/03000605261417865","DOIUrl":"10.1177/03000605261417865","url":null,"abstract":"<p><p>Ventilator-associated pneumonia substantially increases mortality and imposes a heavy burden on healthcare resources. Patients undergoing endotracheal intubation and mechanical ventilation in emergency departments face a particularly high risk of ventilator-associated pneumonia. Compared with healthcare providers in intensive care units, those in emergency departments often lack sufficient awareness of timely and systematic ventilator-associated pneumonia prevention strategies, and existing intensive care unit-based care bundles are rarely tailored to emergency department-specific constraints. This gap leads to suboptimal implementation of ventilator-associated pneumonia preventive measures and increases the risk of ventilator-associated pneumonia. In this narrative review, we synthesize the current evidence on ventilator-associated pneumonia prevention and assess the feasibility of care bundles in resource-constrained emergency department settings. We propose the use of position, hand hygiene, airway, sedation, and equipment-a structured, multicomponent ventilator-associated pneumonia prevention strategy-in emergency departments with limited resources, supported by enabling strategies such as electronic checklists, multidisciplinary collaboration, and training to ensure adherence. Moving forward, efforts should focus on establishing consensus on emergency department-specific ventilator-associated pneumonia prevention protocols and optimizing nursing resource allocation to support implementation.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261417865"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12946409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147306997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-16DOI: 10.1177/03000605261420914
Yufan Pu, Xiang Zhou, Xuejing Li, Jiang Xu
BackgroundSepsis remains a leading cause of mortality in critically ill patients, necessitating the identification of reliable prognostic markers. The triglyceride glucose-body mass index, which combines lipid and glucose metabolism, may serve as a valuable predictor of long-term outcomes in this population.MethodsThis study employed a retrospective observational cohort design and analyzed data from the MIMIC-IV database encompassing 2424 septic patients admitted between 2008 and 2019. Patients were categorized into quartiles based on triglyceride glucose-body mass index values. The primary outcomes assessed were all-cause mortality rates at 30, 90, and 180 days as well as 1-year post-admission, and analysis was performed using multivariable Cox proportional hazards models.ResultsIn total, 2424 septic patients meeting the inclusion criteria were finally included in the analyses. Lower triglyceride glucose-body mass index values have been associated with higher long-term mortality outcomes in critically ill septic patients. However, higher triglyceride glucose-body mass index quartiles were associated with a significant reduction in mortality risk at 180 days and 1 year after admission, even after adjustment for potential confounding variables. Patients in the third (hazard ratio: 0.81, 95% confidence interval: 0.67-0.98, p = 0.028) and fourth (hazard ratio: 0.73, 95% confidence interval: 0.56-0.96, p = 0.026) quartiles exhibited significantly lower hazard ratios for mortality than those in the lowest quartile. Notably, no significant associations were observed with 30-day mortality, suggesting that triglyceride glucose-body mass index values are more strongly associated with long-term outcomes.ConclusionIn this retrospective cohort study, lower triglyceride glucose-body mass index values were associated with higher long-term mortality in critically ill septic patients. Our findings suggest that the triglyceride glucose-body mass index serves as a useful prognostic marker and can help identify patients at increased risk of mortality. These results highlight a potential association that warrants further investigation in prospective studies to clarify the role of triglyceride glucose-body mass index in sepsis management.
{"title":"Association between triglyceride glucose-body mass index and all-cause mortality in patients with sepsis: Evidence from a retrospective cohort study.","authors":"Yufan Pu, Xiang Zhou, Xuejing Li, Jiang Xu","doi":"10.1177/03000605261420914","DOIUrl":"10.1177/03000605261420914","url":null,"abstract":"<p><p>BackgroundSepsis remains a leading cause of mortality in critically ill patients, necessitating the identification of reliable prognostic markers. The triglyceride glucose-body mass index, which combines lipid and glucose metabolism, may serve as a valuable predictor of long-term outcomes in this population.MethodsThis study employed a retrospective observational cohort design and analyzed data from the MIMIC-IV database encompassing 2424 septic patients admitted between 2008 and 2019. Patients were categorized into quartiles based on triglyceride glucose-body mass index values. The primary outcomes assessed were all-cause mortality rates at 30, 90, and 180 days as well as 1-year post-admission, and analysis was performed using multivariable Cox proportional hazards models.ResultsIn total, 2424 septic patients meeting the inclusion criteria were finally included in the analyses. Lower triglyceride glucose-body mass index values have been associated with higher long-term mortality outcomes in critically ill septic patients. However, higher triglyceride glucose-body mass index quartiles were associated with a significant reduction in mortality risk at 180 days and 1 year after admission, even after adjustment for potential confounding variables. Patients in the third (hazard ratio: 0.81, 95% confidence interval: 0.67-0.98, <i>p</i> = 0.028) and fourth (hazard ratio: 0.73, 95% confidence interval: 0.56-0.96, <i>p</i> = 0.026) quartiles exhibited significantly lower hazard ratios for mortality than those in the lowest quartile. Notably, no significant associations were observed with 30-day mortality, suggesting that triglyceride glucose-body mass index values are more strongly associated with long-term outcomes.ConclusionIn this retrospective cohort study, lower triglyceride glucose-body mass index values were associated with higher long-term mortality in critically ill septic patients. Our findings suggest that the triglyceride glucose-body mass index serves as a useful prognostic marker and can help identify patients at increased risk of mortality. These results highlight a potential association that warrants further investigation in prospective studies to clarify the role of triglyceride glucose-body mass index in sepsis management.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261420914"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12914071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146207238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-28DOI: 10.1177/03000605261427147
Guoqing Wang, Liuliang Zhang, Xiaolan Zhu, Kai Qian, Lin Zhu, Boqian Chen, Wanjian Gu, Tao Guo, Shijia Liu
ObjectiveThis study aimed to evaluate the potential of hepatocyte-derived fibrinogen-related protein 1 (HFREP1) as a biomarker for community-acquired pneumonia and community-acquired pneumonia secondary to sepsis.MethodThis cross-sectional observational study included 124 patients with community-acquired pneumonia, 52 patients with community-acquired pneumonia-sepsis, and 123 healthy controls. Clinical data were collected, including procalcitonin and C-reactive protein levels. Serum HFREP1 concentrations were measured, and statistical analyses were performed.ResultHFREP1 levels differed significantly among the healthy control, community-acquired pneumonia, and community-acquired pneumonia-sepsis groups (37.2 vs. 211.6 vs. 696.8 ng/mL). Binary logistic regression analysis identified procalcitonin and HFREP1 as independent predictors of community-acquired pneumonia-sepsis, while C-reactive protein was not an independent predictor. The area under the curve for HFREP1 in distinguishing community-acquired pneumonia patients from healthy controls was 0.8810. For differentiating community-acquired pneumonia-sepsis from community-acquired pneumonia, the area under the curves were 0.8814 for HFREP1, 0.8167 for C-reactive protein, and 0.8902 for procalcitonin.ConclusionHFREP1 may serve as a biomarker for community-acquired pneumonia and community-acquired pneumonia-sepsis. In community-acquired pneumonia-sepsis, HFREP1 was strongly correlated with C-reactive protein and procalcitonin, and its diagnostic performance was comparable to that of procalcitonin.
目的本研究旨在评估肝细胞源性纤维蛋白原相关蛋白1 (HFREP1)作为社区获得性肺炎和社区获得性肺炎继发脓毒症的生物标志物的潜力。方法本横断面观察研究纳入124例社区获得性肺炎患者、52例社区获得性肺炎脓毒症患者和123例健康对照。收集临床数据,包括降钙素原和c反应蛋白水平。测定血清HFREP1浓度,并进行统计学分析。结果frep1水平在健康对照组、社区获得性肺炎组和社区获得性肺炎-脓毒症组之间差异有统计学意义(37.2 vs。211.6 vs。696.8 ng / mL)。二元logistic回归分析发现降钙素原和HFREP1是社区获得性肺炎-败血症的独立预测因子,而c反应蛋白不是独立预测因子。HFREP1在区分社区获得性肺炎患者和健康对照组中的曲线下面积为0.8810。鉴别社区获得性肺炎脓毒症与社区获得性肺炎,HFREP1曲线下面积为0.8814,c反应蛋白曲线下面积为0.8167,降钙素原曲线下面积为0.8902。结论hfrep1可能是社区获得性肺炎和社区获得性肺炎脓毒症的生物标志物。在社区获得性肺炎脓毒症中,HFREP1与c反应蛋白和降钙素原密切相关,其诊断效能与降钙素原相当。
{"title":"Role of hepatocyte-derived fibrinogen-related protein 1 as a serum biomarker in the diagnosis of community-acquired pneumonia and sepsis: A cross-sectional study.","authors":"Guoqing Wang, Liuliang Zhang, Xiaolan Zhu, Kai Qian, Lin Zhu, Boqian Chen, Wanjian Gu, Tao Guo, Shijia Liu","doi":"10.1177/03000605261427147","DOIUrl":"10.1177/03000605261427147","url":null,"abstract":"<p><p>ObjectiveThis study aimed to evaluate the potential of hepatocyte-derived fibrinogen-related protein 1 (HFREP1) as a biomarker for community-acquired pneumonia and community-acquired pneumonia secondary to sepsis.MethodThis cross-sectional observational study included 124 patients with community-acquired pneumonia, 52 patients with community-acquired pneumonia-sepsis, and 123 healthy controls. Clinical data were collected, including procalcitonin and C-reactive protein levels. Serum HFREP1 concentrations were measured, and statistical analyses were performed.ResultHFREP1 levels differed significantly among the healthy control, community-acquired pneumonia, and community-acquired pneumonia-sepsis groups (37.2 vs. 211.6 vs. 696.8 ng/mL). Binary logistic regression analysis identified procalcitonin and HFREP1 as independent predictors of community-acquired pneumonia-sepsis, while C-reactive protein was not an independent predictor. The area under the curve for HFREP1 in distinguishing community-acquired pneumonia patients from healthy controls was 0.8810. For differentiating community-acquired pneumonia-sepsis from community-acquired pneumonia, the area under the curves were 0.8814 for HFREP1, 0.8167 for C-reactive protein, and 0.8902 for procalcitonin.ConclusionHFREP1 may serve as a biomarker for community-acquired pneumonia and community-acquired pneumonia-sepsis. In community-acquired pneumonia-sepsis, HFREP1 was strongly correlated with C-reactive protein and procalcitonin, and its diagnostic performance was comparable to that of procalcitonin.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261427147"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12953943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147321687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-03-03DOI: 10.1177/03000605261421026
Jian-Bo Song, Jian-Ting Xu, Li-Cong Shao, Huan Luo, Jia-Hao Chen, Li Lv, Xing-Nan Ye, Xu-Dong Wu
BackgroundCoronavirus disease 2019 (COVID-19) is a serious global health threat, and some patients with COVID-19 develop post-COVID-19 symptoms, which are characterized by symptoms following acute infection. In December 2022, China relaxed its strict COVID-19 policies, which was followed by outbreaks. Therefore, it is important to investigate post-COVID-19 symptoms in China to understand their prevalence and risk factors. This multicenter study examined post-COVID-19 symptoms among Chinese healthcare workers to better understand their epidemiology.MethodsHealthcare workers from seven hospitals who met specific COVID-19 and work criteria participated in an anonymous online survey conducted from 17 July to 19 August 2023. The collected data were analyzed using various statistical methods to identify factors associated with self-reported post-COVID-19 symptoms.ResultsOf the 5213 healthcare workers who were included in the study, 17.0% reported post-COVID-19 symptoms. Binary logistic regression confirmed male sex (odds ratio = 1.418, 95% confidence interval: 1.151-1.747), doctor/nurse position (doctor: odds ratio = 1.406, 95% confidence interval: 1.074-1.840; nurse: odds ratio = 1.516, 95% confidence interval: 1.176-1.954), chronic respiratory disease (odds ratio = 1.576, 95% confidence interval: 1.035-2.399), moderate/severe COVID-19 (odds ratio = 1.583, 95% confidence interval: 1.323-1.894), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection (odds ratio = 1.420, 95% confidence interval: 1.219-1.655), and high self-reported COVID-19 severity (odds ratio = 1.707, 95% confidence interval: 1.456-2.001) as post-COVID-19-associated factors.ConclusionOur real-world multicenter study showed that 17% of healthcare workers developed post-COVID-19 symptoms following SARS-CoV-2 infection. Therefore, targeted interventions are required for healthcare workers. This study provides important insights into the prevention and management of COVID-19 in healthcare workers and the general population.
{"title":"Prevalence of and risk factors for post-coronavirus disease 2019 symptoms after severe acute respiratory syndrome coronavirus 2 infection in healthcare workers: A multicenter cross-sectional study in China.","authors":"Jian-Bo Song, Jian-Ting Xu, Li-Cong Shao, Huan Luo, Jia-Hao Chen, Li Lv, Xing-Nan Ye, Xu-Dong Wu","doi":"10.1177/03000605261421026","DOIUrl":"10.1177/03000605261421026","url":null,"abstract":"<p><p>BackgroundCoronavirus disease 2019 (COVID-19) is a serious global health threat, and some patients with COVID-19 develop post-COVID-19 symptoms, which are characterized by symptoms following acute infection. In December 2022, China relaxed its strict COVID-19 policies, which was followed by outbreaks. Therefore, it is important to investigate post-COVID-19 symptoms in China to understand their prevalence and risk factors. This multicenter study examined post-COVID-19 symptoms among Chinese healthcare workers to better understand their epidemiology.MethodsHealthcare workers from seven hospitals who met specific COVID-19 and work criteria participated in an anonymous online survey conducted from 17 July to 19 August 2023. The collected data were analyzed using various statistical methods to identify factors associated with self-reported post-COVID-19 symptoms.ResultsOf the 5213 healthcare workers who were included in the study, 17.0% reported post-COVID-19 symptoms. Binary logistic regression confirmed male sex (odds ratio = 1.418, 95% confidence interval: 1.151-1.747), doctor/nurse position (doctor: odds ratio = 1.406, 95% confidence interval: 1.074-1.840; nurse: odds ratio = 1.516, 95% confidence interval: 1.176-1.954), chronic respiratory disease (odds ratio = 1.576, 95% confidence interval: 1.035-2.399), moderate/severe COVID-19 (odds ratio = 1.583, 95% confidence interval: 1.323-1.894), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection (odds ratio = 1.420, 95% confidence interval: 1.219-1.655), and high self-reported COVID-19 severity (odds ratio = 1.707, 95% confidence interval: 1.456-2.001) as post-COVID-19-associated factors.ConclusionOur real-world multicenter study showed that 17% of healthcare workers developed post-COVID-19 symptoms following SARS-CoV-2 infection. Therefore, targeted interventions are required for healthcare workers. This study provides important insights into the prevention and management of COVID-19 in healthcare workers and the general population.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261421026"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12957574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147344417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-08DOI: 10.1177/03000605261417447
Ren Xu, Xiaona Wang, Junqin Zhang, Yanan Ren, Luyang Su, Lu Sang, Jianzhi Su
ObjectiveThis study aimed to evaluate the safety profile of progesterone by analyzing adverse event data from the Food and Drug Administration Adverse Event Reporting System (FAERS) between 2004 and 2024.Materials and methodsThis retrospective, observational pharmacovigilance study was based on data from the FAERS database. A total of 1827 adverse event reports associated with progesterone were retrieved. Disproportionality analysis methods, including the reporting odds ratio, proportional reporting ratio, Bayesian confidence propagation neural network, and multi-item gamma Poisson shrinker, were used to evaluate the frequency, signal strength, and time-to-onset of adverse events.ResultsAmong 24,589,239 adverse event reports in the reporting system, 1827 were associated with progesterone, covering 22 system organ classes and 152 preferred terms. The most frequently reported preferred terms were maternal exposure during pregnancy (151 cases), spontaneous abortion (144 cases), and abnormal product odor (114 cases). The top three preferred terms showing the strongest signals were decidual cast (reporting odds ratio: 2825.23), chondrodermatitis nodularis chronica helicis (reporting odds ratio: 3897.61), and autoimmune dermatitis (reporting odds ratio: 1519.29). Most adverse events occurred within 30 to 180 days after exposure. Newly identified preferred terms associated with progesterone included acute eosinophilic pneumonia, meningioma, and autoimmune dermatitis.ConclusionsThis study identified notable safety concerns associated with progesterone use and detected several rare adverse events. These findings underscore the need for continued monitoring, updated prescribing guidelines, and further investigation into progesterone formulations and adverse event mechanisms.
{"title":"Safety profile of progesterone: Insights from an FDA Adverse Event Reporting System (FAERS)-based pharmacovigilance study.","authors":"Ren Xu, Xiaona Wang, Junqin Zhang, Yanan Ren, Luyang Su, Lu Sang, Jianzhi Su","doi":"10.1177/03000605261417447","DOIUrl":"10.1177/03000605261417447","url":null,"abstract":"<p><p>ObjectiveThis study aimed to evaluate the safety profile of progesterone by analyzing adverse event data from the Food and Drug Administration Adverse Event Reporting System (FAERS) between 2004 and 2024.Materials and methodsThis retrospective, observational pharmacovigilance study was based on data from the FAERS database. A total of 1827 adverse event reports associated with progesterone were retrieved. Disproportionality analysis methods, including the reporting odds ratio, proportional reporting ratio, Bayesian confidence propagation neural network, and multi-item gamma Poisson shrinker, were used to evaluate the frequency, signal strength, and time-to-onset of adverse events.ResultsAmong 24,589,239 adverse event reports in the reporting system, 1827 were associated with progesterone, covering 22 system organ classes and 152 preferred terms. The most frequently reported preferred terms were maternal exposure during pregnancy (151 cases), spontaneous abortion (144 cases), and abnormal product odor (114 cases). The top three preferred terms showing the strongest signals were decidual cast (reporting odds ratio: 2825.23), chondrodermatitis nodularis chronica helicis (reporting odds ratio: 3897.61), and autoimmune dermatitis (reporting odds ratio: 1519.29). Most adverse events occurred within 30 to 180 days after exposure. Newly identified preferred terms associated with progesterone included acute eosinophilic pneumonia, meningioma, and autoimmune dermatitis.ConclusionsThis study identified notable safety concerns associated with progesterone use and detected several rare adverse events. These findings underscore the need for continued monitoring, updated prescribing guidelines, and further investigation into progesterone formulations and adverse event mechanisms.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261417447"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-08DOI: 10.1177/03000605251404774
Li Fengzhen, Lu Jinyan, Zhou Honghai, Wu Fengbiao, Xu Zichun, Chen Yulong
<p><p>ObjectiveThis study aimed to provide an updated assessment of the clinical efficacy and safety of arthroscopic debridement combined with platelet-rich plasma injection for the treatment of knee osteoarthritis.MethodsOn 16 August 2025, we systematically searched multiple databases, including the Cochrane Library, Embase, Ovid Medline, PubMed, Web of Science, China Biology Medicine Disc, China National Knowledge Infrastructure, Wanfang, and VIP Chinese Science and Technology Journal Database (VIPC), for randomized controlled trials evaluating the efficacy of arthroscopic debridement combined with platelet-rich plasma injection in the management of knee osteoarthritis. Outcome measures included the following: (a) clinical response rate; (b) visual analog scale score; (c) Lysholm score; (d) Western Ontario and McMaster Universities Osteoarthritis Index score; and (e) adverse reactions. Data were recorded and analyzed using RevMan 5.4 software. The systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, and the research protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO) platform (registration number: CRD420251127571).ResultsA total of 17 studies involving 1587 patients were included. Meta-analysis results showed that compared with the control group, the treatment group demonstrated a statistically significant difference in the overall clinical response rate: odds ratio = 5.38; 95% confidence interval: 3.45, 8.38; <i>p</i> < 0.00001. Subgroup analyses based on follow-up duration (3, 6, and 12 months) demonstrated a <i>p</i> value of 1.00 and I² value of 0%. Meta-analysis results for each subgroup were as follows: odds ratio = 5.66; 95% confidence interval: 2.14, 14.94; <i>p</i> = 0.0005 for 3 months; odds ratio = 5.68; 95% confidence interval: 2.87, 11.27; <i>p</i> < 0.00001 for 6 months; and odds ratio = 5.40; 95% confidence interval: 2.44, 11.96; <i>p</i> < 0.0001 for 12 months. The treatment group also exhibited a statistically significant reduction in visual analog scale scores: mean difference = -0.62; 95% confidence interval: -1.03, -0.20; <i>p</i> = 0.004. Lysholm scores increased significantly in the treatment group: mean difference = 5.07; 95% confidence interval: 2.99, 7.14; <i>p</i> < 0.00001. The Western Ontario and McMaster Universities Osteoarthritis Index score indicated statistically significant difference: mean difference = -8.65; 95% confidence interval: -11.13, -6.18; <i>p</i> < 0.00001. Adverse reaction rate demonstrated no statistically significant difference: odds ratio = 0.73; 95% confidence interval: 0.28, 1.89; <i>P</i> = 0.52.ConclusionThe overall clinical response rate of arthroscopic debridement combined with platelet-rich plasma injection for knee osteoarthritis was significantly higher than that of the control group. The visual analog scale scores were lower, indicating effective pain relief in patient
目的评价关节镜下清创联合富血小板血浆注射治疗膝关节骨性关节炎的临床疗效和安全性。方法于2025年8月16日,系统检索Cochrane Library、Embase、Ovid Medline、PubMed、Web of Science、中国生物医学数据库、中国国家知识基础设施、万方、VIP中国科技期刊数据库(VIPC)等多个数据库,纳入评估关节镜清创联合富血小板血浆注射治疗膝关节骨性关节炎疗效的随机对照试验。结局指标包括:(a)临床缓解率;(b)视觉模拟量表评分;(c) Lysholm乐谱;(d)西安大略和麦克马斯特大学骨关节炎指数评分;(e)不良反应。采用RevMan 5.4软件对数据进行记录和分析。系统评价按照系统评价和荟萃分析指南的首选报告项目进行,研究方案在国际前瞻性系统评价注册(PROSPERO)平台上注册(注册号:CRD420251127571)。结果共纳入17项研究,1587例患者。meta分析结果显示,治疗组与对照组比较,总临床有效率差异有统计学意义:优势比= 5.38;95%置信区间:3.45,8.38;p p值为1.00,I²值为0%。各亚组meta分析结果如下:优势比= 5.66;95%置信区间:2.14,14.94;3个月P = 0.0005;优势比= 5.68;95%置信区间:2.87,11.27;p p = 0.004。治疗组Lysholm评分显著升高:平均差异= 5.07;95%置信区间:2.99,7.14;p p = 0.52。结论关节镜下清创联合富血小板血浆注射治疗膝关节骨性关节炎的临床总有效率明显高于对照组。视觉模拟量表得分较低,表明膝关节骨关节炎患者疼痛得到有效缓解。Lysholm评分较高,表明与对照组相比,膝关节功能有显著改善。西安大略省和麦克马斯特大学骨关节炎指数评分明显低于对照组,反映了关节镜清创联合富血小板血浆注射治疗膝关节骨关节炎通过改善疼痛、僵硬和功能损害的显著疗效。关节镜清创联合富血小板血浆注射组不良反应发生率与对照组无明显差异,说明富血小板血浆注射不会增加不良事件发生的风险。
{"title":"Efficacy of arthroscopic debridement combined with platelet-rich plasma injection for knee osteoarthritis: An updated systematic review and meta-analysis of randomized controlled trials.","authors":"Li Fengzhen, Lu Jinyan, Zhou Honghai, Wu Fengbiao, Xu Zichun, Chen Yulong","doi":"10.1177/03000605251404774","DOIUrl":"10.1177/03000605251404774","url":null,"abstract":"<p><p>ObjectiveThis study aimed to provide an updated assessment of the clinical efficacy and safety of arthroscopic debridement combined with platelet-rich plasma injection for the treatment of knee osteoarthritis.MethodsOn 16 August 2025, we systematically searched multiple databases, including the Cochrane Library, Embase, Ovid Medline, PubMed, Web of Science, China Biology Medicine Disc, China National Knowledge Infrastructure, Wanfang, and VIP Chinese Science and Technology Journal Database (VIPC), for randomized controlled trials evaluating the efficacy of arthroscopic debridement combined with platelet-rich plasma injection in the management of knee osteoarthritis. Outcome measures included the following: (a) clinical response rate; (b) visual analog scale score; (c) Lysholm score; (d) Western Ontario and McMaster Universities Osteoarthritis Index score; and (e) adverse reactions. Data were recorded and analyzed using RevMan 5.4 software. The systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, and the research protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO) platform (registration number: CRD420251127571).ResultsA total of 17 studies involving 1587 patients were included. Meta-analysis results showed that compared with the control group, the treatment group demonstrated a statistically significant difference in the overall clinical response rate: odds ratio = 5.38; 95% confidence interval: 3.45, 8.38; <i>p</i> < 0.00001. Subgroup analyses based on follow-up duration (3, 6, and 12 months) demonstrated a <i>p</i> value of 1.00 and I² value of 0%. Meta-analysis results for each subgroup were as follows: odds ratio = 5.66; 95% confidence interval: 2.14, 14.94; <i>p</i> = 0.0005 for 3 months; odds ratio = 5.68; 95% confidence interval: 2.87, 11.27; <i>p</i> < 0.00001 for 6 months; and odds ratio = 5.40; 95% confidence interval: 2.44, 11.96; <i>p</i> < 0.0001 for 12 months. The treatment group also exhibited a statistically significant reduction in visual analog scale scores: mean difference = -0.62; 95% confidence interval: -1.03, -0.20; <i>p</i> = 0.004. Lysholm scores increased significantly in the treatment group: mean difference = 5.07; 95% confidence interval: 2.99, 7.14; <i>p</i> < 0.00001. The Western Ontario and McMaster Universities Osteoarthritis Index score indicated statistically significant difference: mean difference = -8.65; 95% confidence interval: -11.13, -6.18; <i>p</i> < 0.00001. Adverse reaction rate demonstrated no statistically significant difference: odds ratio = 0.73; 95% confidence interval: 0.28, 1.89; <i>P</i> = 0.52.ConclusionThe overall clinical response rate of arthroscopic debridement combined with platelet-rich plasma injection for knee osteoarthritis was significantly higher than that of the control group. The visual analog scale scores were lower, indicating effective pain relief in patient","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605251404774"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-08DOI: 10.1177/03000605261418802
Hongqun Zhang, Zhuoyin Wang, Yi Jin
This case report describes an exceptionally rare occurrence of severe acute respiratory distress syndrome following laparoscopic appendectomy in a previously healthy 57-year-old male. The patient presented with acute appendicitis and underwent an uncomplicated surgical procedure. Approximately 4 h postoperatively, he developed rapid respiratory deterioration with severe hypoxemia, fulfilling the Berlin criteria for severe acute respiratory distress syndrome (partial pressure of arterial oxygen/fraction of inspired oxygen ratio, 99.2). Other causes, including aspiration, pulmonary embolism, and cardiac failure, were excluded. The patient was managed in the intensive care unit with lung-protective ventilation in accordance with the Acute Respiratory Distress Syndrome Network (ARDSNet) protocol along with antibiotics and corticosteroids. He demonstrated rapid clinical improvement, was extubated on postoperative day 7, and discharged on postoperative day 8. This case highlights that severe acute respiratory distress syndrome, although rare, can complicate routine surgical procedures and underscores the importance of early recognition and multidisciplinary management in achieving favorable outcomes.
{"title":"Severe acute respiratory distress syndrome following laparoscopic appendectomy in a previously healthy middle-aged man: A case report.","authors":"Hongqun Zhang, Zhuoyin Wang, Yi Jin","doi":"10.1177/03000605261418802","DOIUrl":"10.1177/03000605261418802","url":null,"abstract":"<p><p>This case report describes an exceptionally rare occurrence of severe acute respiratory distress syndrome following laparoscopic appendectomy in a previously healthy 57-year-old male. The patient presented with acute appendicitis and underwent an uncomplicated surgical procedure. Approximately 4 h postoperatively, he developed rapid respiratory deterioration with severe hypoxemia, fulfilling the Berlin criteria for severe acute respiratory distress syndrome (partial pressure of arterial oxygen/fraction of inspired oxygen ratio, 99.2). Other causes, including aspiration, pulmonary embolism, and cardiac failure, were excluded. The patient was managed in the intensive care unit with lung-protective ventilation in accordance with the Acute Respiratory Distress Syndrome Network (ARDSNet) protocol along with antibiotics and corticosteroids. He demonstrated rapid clinical improvement, was extubated on postoperative day 7, and discharged on postoperative day 8. This case highlights that severe acute respiratory distress syndrome, although rare, can complicate routine surgical procedures and underscores the importance of early recognition and multidisciplinary management in achieving favorable outcomes.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261418802"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-09DOI: 10.1177/03000605251411151
Yangqi Zhang, Yilang He, Mingling Ma, Hui Dong, Zijian Ma
ObjectiveThis study aimed to investigate whether coenzyme Q10 is effective in preventing exercise-induced oxidative stress and muscle damage.MethodsFourteen randomized controlled studies examining the effects of supplementation with coenzyme Q10 analogs on postexercise oxidative stress and muscle damage were identified through searches in literature databases, including PubMed, the Cochrane Library, Embase, and Web of Science, and then the quality of the included studies was assessed. Quantitative and qualitative analyses were performed.ResultsThe study screened 14 randomized controlled trials that included a total of 433 subjects. The results demonstrated that oral coenzyme Q10 elevated blood coenzyme Q10 concentration (standardized mean difference: 2.710, 95% confidence interval: 1.57-3.85, p < 0.00001) and reduced blood malondialdehyde concentration (standardized mean difference: -0.289, 95% confidence interval: -0.541 to -0.038, p = 0.024). Additionally, oral coenzyme Q10 was found to reduce blood creatine kinase values (standardized mean difference: -1.532, 95% confidence interval: -2.856 to -0.209, p = 0.023), suggesting a potential protective effect on skeletal muscle. The metabolism-related blood lactate and maximal oxygen uptake levels were not affected by coenzyme Q10 (standardized mean difference: -0.68, 95% confidence interval: -1.89 to 0.53, p = 0.271; standardized mean difference: -0.156, 95% confidence interval: -0.79 to 0.478, p = 0.630).ConclusionsCoenzyme Q10 may reduce exercise-induced oxidative stress on blood malondialdehyde and exert a protective effect on muscle; however, no effect was observed from the anaerobic and aerobic metabolism of the organism.
目的探讨辅酶Q10是否能有效预防运动引起的氧化应激和肌肉损伤。方法通过检索PubMed、Cochrane图书馆、Embase和Web of Science等文献数据库,确定了14项研究补充辅酶Q10类似物对运动后氧化应激和肌肉损伤影响的随机对照研究,并对纳入研究的质量进行评估。进行了定量和定性分析。结果本研究筛选了14项随机对照试验,共纳入433名受试者。结果表明,口服辅酶Q10可提高血中辅酶Q10浓度(标准化平均差值:2.710,95%可信区间:1.57-3.85,p
{"title":"Effects of coenzyme Q10 analogs on oxidative stress, muscle, and metabolism after exercise: A meta-analysis and systematic review.","authors":"Yangqi Zhang, Yilang He, Mingling Ma, Hui Dong, Zijian Ma","doi":"10.1177/03000605251411151","DOIUrl":"10.1177/03000605251411151","url":null,"abstract":"<p><p>ObjectiveThis study aimed to investigate whether coenzyme Q10 is effective in preventing exercise-induced oxidative stress and muscle damage.MethodsFourteen randomized controlled studies examining the effects of supplementation with coenzyme Q10 analogs on postexercise oxidative stress and muscle damage were identified through searches in literature databases, including PubMed, the Cochrane Library, Embase, and Web of Science, and then the quality of the included studies was assessed. Quantitative and qualitative analyses were performed.ResultsThe study screened 14 randomized controlled trials that included a total of 433 subjects. The results demonstrated that oral coenzyme Q10 elevated blood coenzyme Q10 concentration (standardized mean difference: 2.710, 95% confidence interval: 1.57-3.85, p < 0.00001) and reduced blood malondialdehyde concentration (standardized mean difference: -0.289, 95% confidence interval: -0.541 to -0.038, p = 0.024). Additionally, oral coenzyme Q10 was found to reduce blood creatine kinase values (standardized mean difference: -1.532, 95% confidence interval: -2.856 to -0.209, p = 0.023), suggesting a potential protective effect on skeletal muscle. The metabolism-related blood lactate and maximal oxygen uptake levels were not affected by coenzyme Q10 (standardized mean difference: -0.68, 95% confidence interval: -1.89 to 0.53, p = 0.271; standardized mean difference: -0.156, 95% confidence interval: -0.79 to 0.478, p = 0.630).ConclusionsCoenzyme Q10 may reduce exercise-induced oxidative stress on blood malondialdehyde and exert a protective effect on muscle; however, no effect was observed from the anaerobic and aerobic metabolism of the organism.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605251411151"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-04DOI: 10.1177/03000605251411746
Danqian Su, Yan Chen, Zhenyu Yang, Xinyu Yuan, Daxiong Zeng, Jian Li, Junhong Jiang
Montgomery T-tube tracheal stent placement is a well-established treatment for severe subglottic stenosis. This procedure is typically performed using a rigid bronchoscope under general anesthesia. However, a major limitation of this approach is the requirement for neck hyperextension, which is not feasible in patients with cervical spine injuries. This report details a complex case of subglottic stenosis in a patient with a cervical spinal cord injury and incomplete paraplegia, in whom conventional Montgomery T-tube tracheal stent placement was difficult to achieve. We performed Montgomery T-tube tracheal stent implantation under conscious sedation with oxygen support provided by high-flow nasal cannula, minimizing the risks of general anesthesia and cervical manipulation. The successful outcome suggests that the combination of conscious sedation and high-flow nasal cannula may represent a safe and practical strategy for treating carefully selected complex airway cases. Although this case highlights a promising pathway, further studies are required to confirm the efficacy of this strategy and define its clinical indications in larger patient populations.
{"title":"Montgomery T-tube tracheal stent implantation with high-flow nasal oxygen under conscious sedation: A case report.","authors":"Danqian Su, Yan Chen, Zhenyu Yang, Xinyu Yuan, Daxiong Zeng, Jian Li, Junhong Jiang","doi":"10.1177/03000605251411746","DOIUrl":"10.1177/03000605251411746","url":null,"abstract":"<p><p>Montgomery T-tube tracheal stent placement is a well-established treatment for severe subglottic stenosis. This procedure is typically performed using a rigid bronchoscope under general anesthesia. However, a major limitation of this approach is the requirement for neck hyperextension, which is not feasible in patients with cervical spine injuries. This report details a complex case of subglottic stenosis in a patient with a cervical spinal cord injury and incomplete paraplegia, in whom conventional Montgomery T-tube tracheal stent placement was difficult to achieve. We performed Montgomery T-tube tracheal stent implantation under conscious sedation with oxygen support provided by high-flow nasal cannula, minimizing the risks of general anesthesia and cervical manipulation. The successful outcome suggests that the combination of conscious sedation and high-flow nasal cannula may represent a safe and practical strategy for treating carefully selected complex airway cases. Although this case highlights a promising pathway, further studies are required to confirm the efficacy of this strategy and define its clinical indications in larger patient populations.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605251411746"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12876648/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveThis study examined the association between the systemic immune-inflammation index and urinary incontinence subtypes using data from National Health and Nutrition Examination Survey 2007-2016.MethodsThis cross-sectional study included 21,569 adults. Systemic immune-inflammation index was calculated and log-transformed. Survey-weighted logistic regression analyses, smoothed curve fitting, exploratory threshold analyses, and subgroup analyses stratified by demographic and clinical characteristics were conducted to evaluate its associations with stress urinary incontinence, urgency urinary incontinence, and mixed urinary incontinence.ResultsHigher log10 systemic immune-inflammation index levels were significantly associated with an increased prevalence of stress urinary incontinence. Associations with urgency urinary incontinence and mixed urinary incontinence were weaker, and quartile trends were not statistically significant. Smoothed curve fitting demonstrated monotonic increases for stress urinary incontinence and mixed urinary incontinence, whereas a nonlinear pattern was observed for urgency urinary incontinence, suggesting a potential threshold at a log10 systemic immune-inflammation index of approximately 2.5.ConclusionElevated systemic immune-inflammation index levels were significantly associated with stress urinary incontinence, whereas associations with urgency urinary incontinence and mixed urinary incontinence were weaker and exhibited nonlinear patterns. Longitudinal studies are required to clarify the temporal relationships underlying these associations.
{"title":"Association between systemic immune-inflammation index and urinary incontinence: Evidence from the National Health and Nutrition Examination Survey.","authors":"Feike Ma, Zhi-Cheng Cong, Hao Zhang, Yi-Han Chen, Yi-Lun Cui, Yue Duan, Ting-Ting Tao","doi":"10.1177/03000605261419655","DOIUrl":"https://doi.org/10.1177/03000605261419655","url":null,"abstract":"<p><p>ObjectiveThis study examined the association between the systemic immune-inflammation index and urinary incontinence subtypes using data from National Health and Nutrition Examination Survey 2007-2016.MethodsThis cross-sectional study included 21,569 adults. Systemic immune-inflammation index was calculated and log-transformed. Survey-weighted logistic regression analyses, smoothed curve fitting, exploratory threshold analyses, and subgroup analyses stratified by demographic and clinical characteristics were conducted to evaluate its associations with stress urinary incontinence, urgency urinary incontinence, and mixed urinary incontinence.ResultsHigher log<sub>10</sub> systemic immune-inflammation index levels were significantly associated with an increased prevalence of stress urinary incontinence. Associations with urgency urinary incontinence and mixed urinary incontinence were weaker, and quartile trends were not statistically significant. Smoothed curve fitting demonstrated monotonic increases for stress urinary incontinence and mixed urinary incontinence, whereas a nonlinear pattern was observed for urgency urinary incontinence, suggesting a potential threshold at a log<sub>10</sub> systemic immune-inflammation index of approximately 2.5.ConclusionElevated systemic immune-inflammation index levels were significantly associated with stress urinary incontinence, whereas associations with urgency urinary incontinence and mixed urinary incontinence were weaker and exhibited nonlinear patterns. Longitudinal studies are required to clarify the temporal relationships underlying these associations.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 2","pages":"3000605261419655"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146207194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}